PubMed · 16005204
Engineered proteins as specific binding reagents.
Abstract
Over the past 30 years, monoclonal antibodies have become the standard binding proteins and currently find applications in research, diagnostics and therapy. Yet, monoclonal antibodies now face strong competition from synthetic antibody libraries in combination with powerful library selection technologies. More recently, an increased understanding of other natural binding proteins together with advances in protein engineering, selection and evolution technologies has also triggered the exploration of numerous other protein architectures for the generation of designed binding molecules. Valuable protein-binding scaffolds have been obtained and represent promising alternatives to antibodies for biotechnological and, potentially, clinical applications.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H Kaspar Binz, Andreas Plückthun. 2005. Engineered proteins as specific binding reagents.. https://doi.org/10.1016/j.copbio.2005.06.005
Cite the original work for its findings. Save a collection to share your selection of sources.